Anti-inflammatory drugs for controlling asthma. Tips on what to use and when

Postgraduate Medicine

Volumn 104, Issue 3, 1998, Pages 127-139

  Volcheck, Gerald W ^a   O'Connell, Edward J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL SODIUM; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ARTICLE; ASTHMA; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; HUMAN; INCIDENCE; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0031708731     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.09.578     Document Type: Article

References (27)

1. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326(13):862-6
2. Sheffer AL, Bailey WC, Bleeker ER, et al, for the National Heart, Lung, and Blood Institute. National Asthma Education Program expert panel report. Guidelines for the diagnosis and management of asthma. Bethesda: Dept of Health and Human Services, 1991; NIH publication No. 91-3042
3. Messer JW, Peters GA, Bennett WA. Causes of death and pathologic findings in 304 cases of bronchial asthma. Dis Chest 1960;38:616-24
4. Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139(3):806-17
5. Kirby JG, Hargreave FE, Gleich GJ, et al. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987;136(2):379-83
6. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323(15):1033-9
7. Walker C, Bode E, Boer L, et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146(1):109-15
8. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, cromolyn, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79(5):734-40
9. Spector SL. Leukotriene inhibitors and antagonists in asthma. Ann Allergy Asthma Immunol 1995;75(6 Pt 1):463-70, 473; quiz 473-4
10. Sheffer AL, Buist AS, Busse W, et al, for the National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program expert panel report 2. Guidelines for the diagnosis and management of asthma. Bethesda: Dept of Health and Human Services, 1997; NIH publication No. 97-4051
11. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332(13):868-75
12. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88(5):373-81
13. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331(11):700-5
14. Wales JK, Barnes ND, Swift PG. Growth retardation in children on steroids for asthma. (Letter) Lancet 1991; 338(8781):1535
15. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61(11):1049-55
16. Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994;93(6):967-76
17. Kamada AK, Szefler SJ, Martin RJ, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med 1996;153(6 Pt 1):1739-48
18. Cartier A. Anti-allergic drugs. In: O'Byrne PM, Thomson NC, eds. Manual of asthma management. London: Saunders, 1995:254-60
19. Sly MR. New guidelines for diagnosis and management of asthma. Ann Allergy Asthma Immunol 1997;78:427-37
20. Norris AA. Pharmacology of sodium cromoglycate. Clin Exp Allergy 1996; 26(Suppl4):5-7
21. Diaz P, Galleguillos FR, Gonzalez MC, et al. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol 1984;74(1):41-8
22. Parnham MJ. Sodium cromoglycate and nedocromil sodium in the therapy of asthma, a critical comparison. Pulm Pharmacol 1996;9(2):95-105
23. Holgate ST, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996;98(1):1-13
24. Lockey RF, Lavins BJ, Snader L. Effects of 13 weeks of treatment with ICI 204,219 (Accolate) in patients with mild to moderate asthma. (Abstr) J Allergy Clin Immunol 1995;95(1 Pt 2):350
25. Nathan RA, Glass M, Snader L. Effects of 13 weeks of treatment with ICI 204,219 (Accolate) or cromolyn sodium (Intal) in patients with mild to moderate asthma. (Abstr) J Allergy Clin Immunol 1995;95(1 Pt 2):388
26. Israel E, Rubin P, Kemp JP, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993;119(11):1059-66
27. Zileuton for asthma. Med Lett Drugs Ther 1997;39(995):18-9